Report - Caso Clínico: Mieloma Múltiplo elegível a TMO...> = PR 14.0% 66,3% 92,3% 9.1% 56,2% 83,4 % 0.22 0.05 0.01 Stage 3: 20% vs 4% CR High Risk: 23% vs 8% CR IFM 2013-04 ( 4 Cycles) -Number

Please pass captcha verification before submit form